Effective August 1st, 2026, all Generic Drugs being brought intothe United States will continue to have a TARIFF of ZEROPERCENT for a two year period of time, after which the TARIFFwill be raised to 100% for a one year period of time, and 200%thereafter. This is done in order to RESHORE GenericPharmaceutical Production into America, with a penalty to thoseCompanies that decide not to build Plant and Equipment withinthe stated period of time given to them. The objective of thisPolicy is to protect the people of the United States. The Policy onPatented, Branded, or Innovative Drugs, which has been sosuccessful, will remain as is. Pharmaceutical Facilities are beingbuilt, at a level never seen before, all over the United States ofAmerica. Thank you for your attention to this matter! PresidentDONALD J. TRUMP